STAMFORD, Conn. – August 13, 2020 – Avrio Health L.P., a subsidiary of Purdue Pharma L.P. (“Purdue”), is reporting encouraging preliminary results of an in vitro (laboratory) study assessing Betadine® Antiseptic Sore Throat Gargle (active ingredient, povidone-iodine or “PVP-I”) against the virus causing COVID-19. Preliminary results show Betadine Gargle killed 99.9 percent of the virus within 15 seconds. […]

STAMFORD, Conn. – August 11, 2020 – Avrio Health L.P. (Avrio), a subsidiary of Purdue Pharma L.P. (Purdue), today announced the launch of new Betadine® Antiseptic Sore Throat Gargle (active ingredient povidone-iodine, or PVP-I), an oral antiseptic with use for the temporary relief of occasional sore throat. This new gargle, which will be available in […]

 STAMFORD, Conn. – July 16, 2020 – Avrio Health L.P. (“Avrio”), a subsidiary of Purdue Pharma L.P. (“Purdue”), has donated shipments of Betadine Solution and Surgical Scrub to Direct Relief, advancing the company’s previous commitment to donate $1.6 million worth of Betadine antiseptic products (active ingredient, povidone-iodine or “PVP-I”) for use by frontline healthcare workers. […]

STAMFORD, Conn. – May 19, 2020 – Avrio Health L.P., a subsidiary of Purdue Pharma L.P. (“Purdue”), has initiated a program to evaluate the potential safety and virucidal effectiveness of certain formulations of Betadine® antiseptic products (active ingredient, povidone-iodine or “PVP-I”) against the virus causing COVID-19. An in vitro study evaluating activity against a surrogate coronavirus has begun, with additional […]

STAMFORD, Conn. – April 27, 2020 – Today, Avrio Health L.P., a subsidiary of Purdue Pharma L.P. (“Purdue”), announced plans to donate $1.6 million worth of Betadine antiseptic products (active ingredient, povidone-iodine or “PVP-I”) for use by frontline healthcare workers. Betadine Solution and Betadine Surgical Scrub are antiseptic products used to reduce the number of […]